Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06160427 · ClinicalTrials.gov registry record · Phase 4

Connective Tissue Matrix for Rotator Cuff Tendinopathy

A Phase 4 study of Shoulder Pain and Tendinopathy, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Active
Registry status
Phase 4
Development phase
92
Enrollment target
4
Study locations

NCT06160427 is a Phase 4 study of Shoulder Pain and Tendinopathy that is active but no longer recruiting, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 92 participants, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target. The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06160427, a Phase 4 study of Shoulder Pain and Tendinopathy, is active but no longer recruiting, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
92 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.

Conditions Studied

Shoulder Pain Tendinopathy Rotator Cuff Tendinitis Rotator Cuff Tendinosis

Interventions

  • BIOLOGICAL CTM Boost
  • BIOLOGICAL PRP

Study Locations (4)

Pennsylvania

  • Allegheny Health Network Allegheny General Hospital - Pittsburgh
  • Allegheny Health Network Federal North Medical Office Building - Pittsburgh
  • AHN Wexford Health & Wellness Pavilion - Wexford
  • AHN Wexford Hospital - Wexford

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2023-12-04
Est. Completion 2028-01-15
Phase Phase 4

Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06160427

The ClinicalTrials.gov registry entry for NCT06160427 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which CTM Boost is the first listed.

NCT06160427 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06160427 about?

NCT06160427 is a clinical study titled "Connective Tissue Matrix for Rotator Cuff Tendinopathy". The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.

What is the current status of trial NCT06160427?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2023-12-04. Estimated completion is 2028-01-15.

What conditions does trial NCT06160427 study?

This clinical trial studies the following conditions: Shoulder Pain, Tendinopathy, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis.

What interventions are being tested in trial NCT06160427?

The interventions under investigation include: CTM Boost (BIOLOGICAL), PRP (BIOLOGICAL).

Who is sponsoring clinical trial NCT06160427?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06160427 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Shoulder Pain

All registered trials for this condition

Tendinopathy

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.